Literature DB >> 27940061

Hemodialyzer Reuse and Gram-Negative Bloodstream Infections.

Chris Edens1, Jacklyn Wong2, Meghan Lyman3, Kyle Rizzo4, Duc Nguyen5, Michela Blain5, Sam Horwich-Scholefield4, Heather Moulton-Meissner5, Erin Epson4, Jon Rosenberg4, Priti R Patel5.   

Abstract

BACKGROUND: Clusters of bloodstream infections caused by Burkholderia cepacia and Stenotrophomonas maltophilia are uncommon, but have been previously identified in hemodialysis centers that reprocessed dialyzers for reuse on patients. We investigated an outbreak of bloodstream infections caused by B cepacia and S maltophilia among hemodialysis patients in clinics of a dialysis organization. STUDY
DESIGN: Outbreak investigation, including matched case-control study. SETTING & PARTICIPANTS: Hemodialysis patients treated in multiple outpatient clinics owned by a dialysis organization. PREDICTORS: Main predictors were dialyzer reuse, dialyzer model, and dialyzer reprocessing practice. OUTCOMES: Case patients had a bloodstream infection caused by B cepacia or S maltophilia; controls were patients without infection dialyzed at the same clinic on the same day as a case; results of environmental cultures and organism typing.
RESULTS: 17 cases (9 B cepacia and 8 S maltophilia bloodstream infections) occurred in 5 clinics owned by the same dialysis organization. Case patients were more likely to have received hemodialysis with a dialyzer that had been used more than 6 times (matched OR, 7.03; 95% CI, 1.38-69.76) and to have been dialyzed with a specific reusable dialyzer (Model R) with sealed ends (OR, 22.87; 95% CI, 4.49-∞). No major lapses during dialyzer reprocessing were identified that could explain the outbreak. B cepacia was isolated from samples collected from a dialyzer header-cleaning machine from a clinic with cases and was indistinguishable from a patient isolate collected from the same clinic, by pulsed-field gel electrophoresis. Gram-negative bacteria were isolated from 2 reused Model R dialyzers that had undergone the facility's reprocessing procedure. LIMITATIONS: Limited statistical power and overmatching; few patient isolates and dialyzers available for testing.
CONCLUSIONS: This outbreak was likely caused by contamination during reprocessing of reused dialyzers. Results of this and previous investigations demonstrate that exposing patients to reused dialyzers increases the risk for bloodstream infections. To reduce infection risk, providers should consider implementing single dialyzer use whenever possible. Published by Elsevier Inc.

Entities:  

Keywords:  Burkholderia cepacia; Gram-negative bacteria; Hemodialysis; Stenotrophomonas maltophilia; bloodstream infection (BSI); case-control; contamination; decontamination; dialysis organization; dialyzer reprocessing; dialyzer reuse; end-stage renal disease (ESRD); human error; infection prevention; outbreak; patient safety

Mesh:

Year:  2016        PMID: 27940061      PMCID: PMC5441929          DOI: 10.1053/j.ajkd.2016.09.022

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  26 in total

1.  Evaluation of the effectiveness of manual and automated dialyzers reprocessing after multiple reuses.

Authors:  Alexandra do Rosário Toniolo; Maíra Marques Ribeiro; Marina Ishii; Cely Barreto da Silva; Lycia Mara Jenné Mimica; Kazuko Uchikawa Graziano
Journal:  Am J Infect Control       Date:  2016-02-17       Impact factor: 2.918

2.  Reuse of hemodialyzers. Results of nationwide surveillance for adverse effects.

Authors:  M J Alter; M S Favero; J K Miller; P J Coleman; L A Bland
Journal:  JAMA       Date:  1988-10-14       Impact factor: 56.272

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  National surveillance of dialysis-associated diseases in the United States, 2002.

Authors:  Lyn Finelli; Jeremy T Miller; Jerome I Tokars; Miriam J Alter; Matthew J Arduino
Journal:  Semin Dial       Date:  2005 Jan-Feb       Impact factor: 3.455

5.  Abandoning peracetic acid-based dialyzer reuse is associated with improved survival.

Authors:  Eduardo Lacson; Weiling Wang; Ann Mooney; Norma Ofsthun; J Michael Lazarus; Raymond M Hakim
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 8.237

6.  An outbreak of bloodstream infections arising from hemodialysis equipment.

Authors:  P M Arnow; S Garcia-Houchins; M B Neagle; J L Bova; J J Dillon; T Chou
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

7.  Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers.

Authors:  G Bolan; A L Reingold; L A Carson; V A Silcox; C L Woodley; P S Hayes; A W Hightower; L McFarland; J W Brown; N J Petersen
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

8.  An outbreak of pyrogenic reactions in chronic hemodialysis patients associated with hemodialyzer reuse.

Authors:  J R Rudnick; M J Arduino; L A Bland; L Cusick; S K McAllister; S M Aguero; W R Jarvis
Journal:  Artif Organs       Date:  1995-04       Impact factor: 3.094

9.  Reprocessing dialysers for multiple uses: recent analysis of death risks for patients.

Authors:  Edmund G Lowrie; Zhensheng Li; Norma Ofsthun; J Michael Lazarus
Journal:  Nephrol Dial Transplant       Date:  2004-08-17       Impact factor: 5.992

10.  Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice.

Authors:  Karon Abe; Melissa Tobin D'Angelo; Rebecca Sunenshine; Judith Noble-Wang; James Cope; Bette Jensen; Arjun Srinivasan
Journal:  Infect Control Hosp Epidemiol       Date:  2007-09-19       Impact factor: 3.254

View more
  1 in total

Review 1.  Antimicrobial resistance in nephrology.

Authors:  Tina Z Wang; Rosy Priya L Kodiyanplakkal; David P Calfee
Journal:  Nat Rev Nephrol       Date:  2019-08       Impact factor: 28.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.